Cancer vaccines at the age of immune checkpoint inhibitors: reasonable approach as combination therapy in advanced urothelial carcinoma?
Ann Oncol
.
2017 Apr 1;28(4):680-682.
doi: 10.1093/annonc/mdx063.
Authors
P Grivas
1
,
V S Koshkin
1
,
S K Pal
2
Affiliations
1
Department of Hematology & Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland.
2
Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, USA.
PMID:
28328001
DOI:
10.1093/annonc/mdx063
No abstract available
Publication types
Editorial
Comment
MeSH terms
Cancer Vaccines*
Carcinoma, Transitional Cell*
Humans
Urologic Neoplasms
Substances
Cancer Vaccines